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Ocimum gratissimum (OG) is widely used as a traditional herb for its antibacterial activity in Taiwan. Recently, antitumor eﬀect
of OG on breast cancer cell is also reported; however, the eﬀects of OG on human pulmonary adenocarcinoma cell A549 remain
unclear. Therefore, we aimed to investigate whether aqueous OG extract (OGE) aﬀects viability of A549 cells and the signals
induced by OGE in A549 cells. Cell viability assays revealed that OGE signiﬁcantly and dose-dependently decreased the viability of
A549 cell but not that of BEAS-2B cell. Morphological examination and DAPI staining indicated that OGE induced cell shrinkage
and DNA condensation for A549 cells. Further investigation showed that OGE enhanced activation of caspase-3, caspase-9 and
caspase-8 and increased protein level of Apaf-1 and Bak, but diminished the level of Bcl-2. Additionally, OGE inhibited the
phosphorylation of extracellular signal-regulated kinase (ERK) yet enhanced the phosphorylation of c-Jun N-terminal kinase
(JNK) and p38 MAP kinase (p38). In conclusion, our ﬁndings indicate that OGE suppressed the cell viability of A549 cells, which
may result from the activation of apoptotic signaling and the inhibition of anti-apoptotic signaling, suggesting that OGE might be
beneﬁcial to lung carcinoma treatment.
1.Introduction
Lung adenocarcinoma is the major cause of cancer-related
mortality worldwide [1, 2]. Despite clinical success of con-
currenttherapeuticapproachesagainstlungcancerincluding
chemotherapyandradiotherapy, markedchancesofundesir-
able and adverse side eﬀects caused by such therapies need
to be managed. Use of medicinal plants in chemoprevention
is considered as an ideal treatment with good eﬃcacy and
few side eﬀects compared with allopathic medicine [3].
Mounting evidences have shown that dietary intake of
phytochemicals, an important group of chemopreventive
agents, reduces the risk of cancer [4] and has antitumor
potential against lung cancer [5].
Chemopreventive agents are compounds that prevent
developmentofcancer.Theirpreventiveeﬀectsareattributed
to [1] intervening in interaction of the carcinogen with
cellular DNA, [2] altering intracellular signaling pathways as
results of stopping progression of an initiated cell through
preneoplastic changes into a malignant cell, [3] inhibiting
angiogenesis, [4] inducing cell cycle arrest, and [5] triggering
apoptosis.Itisbelievedthattheapoptosisinducedbychemo-
preventive agents may not only inhibit the carcinogenesis
induced by carcinogens, but also may suppress the growth
of tumor and enhance the cytotoxic eﬀects of antitumor
drug on tumor, which plays a pivotal role in the antitumor
therapies [6].2 Evidence-Based Complementary and Alternative Medicine
The genus Ocimum, belonging to the family Labiatae,
is widely found in tropical and subtropical regions. The
widespread plant is known for its chemopreventive, anticar-
cinogenic, free radical scavenging, and other pharmacologi-
cal properties and used as a traditional herb in European and
Asian countries since ancient times [7]. It has been prepared
in a variety of forms for consumption. The aqueous leaf
extract and seed oil are reported to show chemopreventive
and antiproliferative activity on Hela cells [8]. Ethanolic
extract of Ocimum leaf also has been shown to have sig-
niﬁcant modulatory inﬂuence on carcinogen metabolizing
enzymes including cytochrome P450, cytochrome b5, and
aryl hydrocarbon hydroxylase, glutathione-S-transferase [9,
10]. Additionally, Ocimum sanctum prepared in the form
of fresh leaf paste, aqueous, and ethanolic extract has
been reported to reduce the incidence of papillomas and
squamous cell carcinoma in carcinogen-treated hamsters
with an observation that the aqueous extract exerts more
profound eﬀect than the other two forms [11]. Nevertheless,
the mechanisms of aqueous extract of Ocimum gratissimum
(OGE) underlying its anticancer property remain sketchy.
In the present study, the anticancer eﬀects of OGE
were investigated using human lung carcinoma A549 cells.
The eﬀects of OGE on cell viability and apoptosis of
A549 cell were determined by measuring the activity of
mitochondrial malate dehydrogenase and the DNA con-
densation, respectively. The OGE-induced caspase activation
cascades and kinase signaling, including caspase-3, caspase-
8,caspase-9,apaf-1,Bcl-2,Bak,extracellularsignal-regulated
kinase (ERK), Akt, c-Jun N-terminal kinase (JNK), and
p38 mitogen-activated protein (MAP) kinase (p38), were
elucidated using immunological approaches
2.MaterialsandMethods
2.1. Materials. [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT), 4 -6-Diamidino-2-phenylin-
dole (DAPI), penicillin, and streptomycin were purchased
f r o mS i g m a( S t .L o u i s ,M O ) .
Dulbecco’s modiﬁed Eagle’s medium (DMEM), fetal
bovine serum (FBS), and trypsin-EDTA were purchase from
Gibco BRL (Gaithersburg, MD). Antibodies against caspase-
3, caspase-8, caspase-9, apaf-1, Bak, Bcl-2, phosphorylated-
ERK1/2(p-ERK1/2),ERK1/2,phosphorylated-JNK(p-JNK),
JNK, phosphorylated-p38 (p-p38), and p38 were purchased
from Cell Signaling Technologies (Beverly, MA). Antibodies
against β actin and Glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) were obtained from Sigma. HRP-conjugated
secondary antibodies against mouse IgG and rabbit IgG
were purchased from Abcam Inc. (Cambridge, UK). The
lungadenocarcinomacellA549wasobtainedfromAmerican
Type Culture Collection (ATCC; Rockville, MD).
2.2. Preparation of OGE and Composition Analysis. Leaves of
Ocimum gratissimum Linn were harvested and washed with
distilled water followed by homogenization with distilled
water using polytron. The homogenate was incubated at
95
◦C for 1hour (h) and then ﬁltered through two layers
of gauze. The ﬁltrate was centrifuged at 20,000g, 4◦Cf o r
15minute to remove insoluble pellets and the supernatant
(OGE) was thereafter collected, lyophilized, and stored at
−70
◦C until use.
ThecontentofpolyphenolinOGEwasanalyzedasprevi-
ously described in [12] and revealed the ﬁnal extract (OGE)
contained 11.1% polyphenolic acid and 4.5% ﬂavonoids.
2.3. Cell Culture and Experimental Treatments. Lung adeno-
carcinoma cell A549 and SV40-transformed normal epithe-
lial cell BEAS-2B were maintained in DMEM supplemented
with10%FBSand100μg/mlpenicillin/streptomycinat37
◦C
in a humidiﬁed atmosphere containing 5% CO2.C e l l sw e r e
seeded in 6-well culture plates at an initial density of 1 ×
105 cells/ml and grown to approximately 80% conﬂuence.
OGE treatments were performed by incubating cells with
serial concentrations of OGE (w/v) in serum-free DMEM for
48h. After the OGE treatments, the cells were washed with
phosphate-buﬀered saline (PBS; 25mM sodium phosphate,
150mM NaCl, pH 7.2) and collected for following analyses.
2.4. DAPI Staining. DAPI staining was performed to assess
morphological changes in the chromatin structure of A549
cells undergoing apoptosis as previously described in [13].
Brieﬂy, cells were trypsinized, mounted on glass slides, and
ﬁxed in 4% paraformaldehyde for 30minutes. followed by
staining with 1μg/ml DAPI for 30minutes Apoptosis was
characterized by chromatin condensation and fragmentation
when examined by ﬂuorescence microscopy. The incidence
of apoptosis in each treatment was analyzed by counting 300
cells and presented in the percentage of apoptotic cells.
2.5. Cell Viability Assay. Cell viability was determined by
MTTassa y[14]intheabsenceorpresenceof50or100μg/ml
OGE. After 48 h treatments, culture medium was aspirated
and cells were incubated with MTT (0.5mg/ml) at 37
◦Cf o r
4h. The viable cell number was directly proportional to the
production of formazan, which was dissolved in isopropanol
and determined by measuring the absorbance at 570nm
using a microplate reader (SpectraMAX 360pc, Molecular
Devices, Sunnyvale, CA).
2.6. Immunoblotting. A549 cells were washed with PBS and
lysed with lysis buﬀer (50mM Tris-HCl, pH 7.5, 150mM
NaCl, 1% Nonidet P-40, 1mM phenylmethylsulfonyl ﬂu-
oride, 1mM sodium ﬂuoride, and 10μg/ml aprotinin and
leupeptin). The lysates were incubated on ice for 30minutes
and centrifuged at 20,000g for 15minutes. The supernatants
were collected and measured for protein concentration
using Bradford method. Crude proteins (30μgp e rl a n e )
were subjected to a 12.5% SDS-polyacrylamide gel, and
then transferred onto a nitrocellulose membrane (Millipore,
Bedford, MA). The blotted membrane was blocked with
5%w/v skimmed milk in PBS, and then incubated for 2h
with 1/1000 dilution of antibodies against human caspase-3,
caspase-8, caspase-9, apaf-1, Bak, Bcl-2, p-ERK1/2, ERK1/2,
p-JNK, JNK, p-p38, p38, β-actin, and GAPDH, respec-
tively. Antigen-antibody complex weredetected using 1/2000
dilution of peroxidase-conjugated secondary antibodies and
displayedusingECLchemiluminescencereagent(Millipore).Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: OGE diminished cell viability of A549 cell. The cell viability of A549 cells (a) and BEAS-2B cells (b) treated with serial
concentrations of OGE (10, 50, 100, 200 and 300μg/ml) for 48h was determined. Data were expressed as mean ± SEM for 3 independent
experiments.
∗P <. 05 and,
∗∗P <. 01 as comparing to control (c). n.s., no statistical signiﬁcance.
2.7. Statistical Analysis. Data were expressed as means ±
SEMs of the three independent experiments. Statistical
signiﬁcance analysis was determined by using 1-way ANOVA
followed by Dunnett for multiple comparisons with the
control. The diﬀerences were considered signiﬁcant for P
values less than .05.
3. Results
3.1. Growth Suppression of Human Lung Carcinoma A549
Cells by OGE Administration. To examine antitumor activity
of OGE, both lung carcinoma cell A549 and epithelial
cell BEAS-2B were treated with serial concentrations of
OGE (100, 200, 300, 500, and 800μg/ml) for 48h, and
subsequently analyzed for the cell viability. As shown in
Figure 1(a), the viability of A549 cells exposed to OGE
for 48 hours was found decreased in association with the
concentration of OGE in a dose-dependent fashion. The
viability was signiﬁcantly decreased to 92.3 ± 3.2%, 90.1 ±
1.4%, 87.2 ± 1.2%, 70.6 ± 3.3%, and 27.5 ± 1.4% of control
with 100, 200, 300, 500 and 800μg/ml OGE, respectively
(P<. 05 as compared to control). Interestingly, the cell
viability of BEAS-2B was insigniﬁcantly aﬀected by OGE
treatment. However, the variation of the viability was not
statistically signiﬁcant (.061 <P<. 121 as compared to
control) (Figure 1(b)). Accordingly, the ﬁndings showed that
500, and 800μg/ml OGE treatment signiﬁcantly suppressed
the viability of A549 cells but not that of BEAS-2B.
3.2. OGE-Induced Morphological Alteration and DNA Con-
densation in A549 Cells. To explore the mechanism under-
lying cell death in presence of OGE, cell morphology and
chromatin condensation of OGE-treated A549 cells was
examined. As shown in Figure 2(a), OGE treatment altered
the morphology of A549 cells as results of cell shrinkage
and detachment (left panel). Additionally, a phenomenon
of chromatin condensation was observed in the A549 cells
treatedwith OGEin a dose-dependent manner (right panel).
TheincidenceofDNAcondensationwasquantiﬁed,showing
that500and800μg/mlOGEtreatmentresultedinsigniﬁcant
chromatin condensation (17.5 ± 1.7% and 56.8 ± 2.3%, P<
.01 as compared to control) in A549 cell (Figure 2(b)).
3.3. Activation of Both Intrinsic and Extrinsic Apoptotic Path-
way in A549 Cells following OGE Treatment. To discriminate
the apoptotic mechanisms induced by OGE treatment, the
activations of intrinsic and extrinsic caspase cascades were
investigated. As shown in Figure 3, the level of procaspase-3,
an important eﬀecter caspase, was decreased in response to
OGE treatment in a dose-dependent manner. Concomitant
with the decrease of procaspase-3, the increase in cleaved
caspase-3 in A549 cells was observed in association with
OGE treatment in a dose-dependent fashion. The con-
tent of caspase-9 and Apaf-1, two upstream activators of
procaspase-3 in intrinsic pathway, were further investigated.
The treatment of A549 cells with OGE resulted in the
decrease of procaspase-9 and the increase of its cleavage
product. The level of Apaf-1 was also dose-dependently
increased by OGE treatment (Figure 3).
The eﬀect of OGE treatment on caspase-8, an upstream
activator of caspase-3 in extrinsic pathway, was also inves-
tigated. Although no obvious change in the level of
procaspase-8 was observed in presence of OGE, the levels of
two cleaved caspase-8 (43kDa and 12kDa) were remarkably
increased by OGE treatment (Figure 4).
3.4. Modulation of Bak and Bcl-2 in OGE-Treated A549
Cells. To further elucidate the putative mechanism under-
lying the OGE-associated apoptotic signaling, the levels of
proapoptotic proteins Bak and antiapoptotic proteins Bcl-
2 at various concentrations of OGE were examined. After
being normalized and veriﬁed with GAPDH, expression of
Bax was increased remarkably in a dose-dependent manner.
Moreover, an obvious decrease in the Bcl-2 protein level was
detected in the OGE-treated A549 cells as compared to the
control (Figure 5(a)).4 Evidence-Based Complementary and Alternative Medicine
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Figure 2:OGEalteredcellmorphologyandinducedDNAcondensationofA549cell.A549cellsweretreatedwith0,500and800μg/mlOGE
for 48 h and then stained with DAPI. (a) The cell morphology and the DNA condensation was photographed by ﬂuorescence microscopy
(200x). The cells presented DNA condensation were indicated by arrow. (b) The incidence of DNA condensation was determined for the
A549 cells with diﬀerent treatments. Data were expressed as mean ± SEM for 3 independent experiments.
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Figure 3:OGEinducedactivationofintrinsic/mitochondrialapop-
totic pathway. A549 cells were treated with 0, 500 and 800μg/ml
for 48hr, and then were lyzed for the determination of protein
levels of caspase-3, cleaved caspase-3, caspase-9, cleaved caspase-9
and Apaf-1 by immunoblotting. β-actin was used as control. The
apparent molecular weights for detected proteins were indicated.
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Cleaved caspase-8
Cleaved caspase-8
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Figure 4: OGE induced activation of caspase-8. A549 cells were
treated with 0, 500 and 800μg/ml for 48hr, and then were lyzed for
thedeterminationofproteinlevelsofcaspase-8andcleavedcaspase-
8 by immunoblotting. β actin was used as control. The apparent
molecular weights for detected proteins were indicated.
Quantitative Bak and Bcl-2 expression after being stan-
dardized to GAPDH (n = 3) was shown in Figure 5(b).
Expression of Bak was increased signiﬁcantly upon OGE
treatment, whereas the signiﬁcant decrease in expression of
Bcl-2 in A549 cells. With 800μg/ml OGE treatment, the
level of Bak and Bcl-2 was increased to 321.3 ± 11.4% and
decreased to 50.2 ± 2.2%, respectively (P<. 01 as compared
to control).Evidence-Based Complementary and Alternative Medicine 5
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Figure 5: OGE enhanced protein level of Bak and diminished
protein level of Bcl-2. A549 cells were treated with 0, 500, and
800μg/ml for48hr, and then were lyzed for the determination of
protein levels by immunoblotting. (a) The expression levels of Bak
and Bcl-2 were determined. GAPDH was used as control. (b) The
expression levels of Bak and Bcl-2 were quantitatively expressed
after being standardized to GAPDH. Data are expressed as mean
± SEM for 3 independent experiments for each concentration
point.
∗∗P <. 01 as compared with control.
3.5. Activation of JNK and p38 but Not ERK MAP Kinase
in A549 Cells following OGE Treatment. MAP kinases have
been widely reported for their involvements in the survival,
proliferation, diﬀerentiation, and apoptosis in diﬀerent
cancer cells [15]. Therefore, the inﬂuence of OGE treatment
on activation of three important MAP kinases, ERK, JNK,
and p38, were further investigated. As shown in Figure 6,
remarkable phosphorylation of ERK, but not JNK and p38,
was detected in the control A549 cells. OGE treatment
signiﬁcantly inhibited the phosphorylation of ERK and
enhanced the phosphorylation of JNK and p38.
4. Discussion
Aberrant cells such as mutated or proliferating neoplastic
cells are removed by programmed cell death, namely,
p-JNK
p-p38
p-ERK1/2
44kDa
42kDa
44kDa
42kDa
54kDa
54kDa
ERK1/2
JNK
p38
43kDa
43kDa
OGE (μg/mL)
500 800 C
Figure 6: OGE inhibited phosphorylation of Erk but enhanced
phosphorylationofJNKandp38.A549cellsweretreatedwith0,500
and 800μg/ml for 48hr, and then were lyzed for the determination
of protein levels by immunoblotting. The levels of p-ERK1/2,
ERK1/2, p-JNK, JNK, p-p38, and p38 were presented.
apoptosis [16]. Two well-known pathways, extrinsic and
intrinsic pathways, are responsible for triggering apoptosis
[17]. In the case of the intrinsic pathway, a release of
cytochrome C from mitochondria results in binding to
Apaf-1 and subsequently leads to activation of procaspase-9
and following caspase-3 [18]. Activated caspase-3 exerts as
the key executioner of apoptosis to induce the cleavage and
inactivation of key cellular protein [18, 19]. In the present
study, it is demonstrated that OGE treatment increased the
Apaf-1 expression level and activated the caspase-9 and 3
cascade. Additionally, it is known that caspase-3 can be
activated by caspase-8 through the extrinsic pathway [20].
Our results showed that OGE treatment simultaneously
induced the activation of caspase-8. These ﬁndings indicate
that both activations of the intrinsic and extrinsic pathway
are of responses to exposure to OGE in A549 cells as results
of apoptosis.
MAP kinase cascades consist of a core of three protein
kinases such as ERK1/2, p38, and JNK pathways [21, 22].
Thus, to understand the molecular mechanism of OGE,
the potential involvement of MAP kinase pathway in OGE-
induced apoptosis was investigated by immunoblotting. The
aberrant expressions of Akt and ERK are known as a promi-
nent feature of many human cancers including nonsmall
cell lung cancer [23]. Our ﬁndings are consistent with the
aberration that a relative high level of ERK phosphorylation
in the control A549 cells, which may contribute to the
malignancy and high frequency of metastasis of lung cancer.
Interestingly, our results that ERK phosphorylation in A549
cells was signiﬁcantly inhibited in presence of OGE suggest
that OGE treatment could have suppressive inﬂuence on
the constitutive survival signaling for A549 cells. Moreover,
the JNK and p38 phosphorylation in A549 cells was found6 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Proposed model for the antitumoral activity of Ocimum
gratissimum extracts on the human lung adenocarcinoma A549.
Our data demonstrated that Ocimum gratissimum extract induces
activation of caspase-3, caspase-9, and caspase-8, which may
attribute to the increase of Apaf-1 and Bak, the decrease of
antiapoptotic Bcl-2, as well as the inhibition of ERK1/2 survival
signaling and the enhancement of JNK and p38 stress signal
cascades.
enhanced in response to OGE treatment, which plays an
important role in apoptotic signaling through regulating the
activities of pre-existing Bcl-2 family proteins and mediating
caspase activation [12].
Recently,severallinesofevidenceindicatethatextractsof
Ocimum species possess antitumor eﬀects. Ethanolic extract
of Ocimum sanctum h a sb e e nr e p o r t e dt oi n d u c ea p o p t o -
sis of A549 cell via the intrinsic/mitochondria-dependent
pathway [24] and chemical-induced gastric carcinogenesis
via inhibition of proliferation, angiogenesis, and apoptosis-
associated proteins [25]. Essential oil from Ocimum sanctum
also has been shown to exert cytotoxic and apoptotic activity
to human colorectal adenocarcinoma cell COLO 205 [26].
Moreover, Ocimum sanctum combining with Azadirachta
indica is reported to have synergistic chemopreventive eﬀects
on chemical-induced gastric carcinogenesis, which may be
attributed to their anti-oxidant, antiangiogenic, antipro-
liferative, and apoptosis inducing properties [27]. These
ﬁndings indicate that Ocimum spp. extracts possess potent
antitumoral activity through inducing apoptosis, inhibiting
proliferation and suppressing angiogenesis.
In the present study, we show that OGE activates both
intrinsicandextrinsicpathwayinA549cells.Aqueousextract
of OG leaf has been reported to inhibit the growth and the
migration of breast cancer cell MDA-MB-231 [28]. With
the treatment of 0.5% (5mg/ml) aqueous extract of OG
leaf for 72h, the cell viability of MDA-MB-231 was reduced
to approximately 60% of the control. Our results reveal
that the lower concentration of OGE (500 and 800μg/ml)
signiﬁcantly diminishes the cell viability of A549 to 47%
and 36% of the control. These ﬁndings suggest that lung
adenocarcinomacellsaremoresusceptibletoOGEtreatment
than breast cancer cells.
In conclusion, the present study provides evidences
that OGE treatments signiﬁcantly alter viability of lung
adenocarcinoma A549 cells through a synergy of induction
of apoptotic signaling and suppression of antiapoptotic
signaling, as shown in Figure 7.M o r e o v e r ,O G Et r e a t m e n t
simultaneously inhibits the activation of ERK and enhances
the activation of JNK and p38, which is consistent with
the enhanced apoptotic signaling and reduced antiapoptotic
signaling based on their well-known eﬀects on these signal
cascades (Figure 7). By manipulating both arms of apoptotic
and antiapoptotic pathway, OGE represents a promisingly
eﬀective chemopreventive agent against lung adenocarci-
noma.
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